+1 347 708 0418
CAR T-Cell Therapy market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global CAR T-Cell Therapy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Allogeneic
Autologous
Segment by Application
Hospitals
Cancer Research Centers
Others
By Company
Celgene (Juno Therapeutics)
Novartis
Gilead (Kite Pharma)
Pfizer
CARsgen Therapeutics
Autolus Therapeutics
Aurora BioPharma
Sorrento Therapeutics
Mustang Bio
Bluebird Bio
Collectis
Allogene Therapeutics
Celyad
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global CAR T-Cell Therapy Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Allogeneic
1.2.3 Autologous
1.3 Market by Application
1.3.1 Global CAR T-Cell Therapy Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospitals
1.3.3 Cancer Research Centers
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global CAR T-Cell Therapy Market Perspective (2017-2028)
2.2 CAR T-Cell Therapy Growth Trends by Region
2.2.1 CAR T-Cell Therapy Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 CAR T-Cell Therapy Historic Market Size by Region (2017-2022)
2.2.3 CAR T-Cell Therapy Forecasted Market Size by Region (2023-2028)
2.3 CAR T-Cell Therapy Market Dynamics
2.3.1 CAR T-Cell Therapy Industry Trends
2.3.2 CAR T-Cell Therapy Market Drivers
2.3.3 CAR T-Cell Therapy Market Challenges
2.3.4 CAR T-Cell Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top CAR T-Cell Therapy Players by Revenue
3.1.1 Global Top CAR T-Cell Therapy Players by Revenue (2017-2022)
3.1.2 Global CAR T-Cell Therapy Revenue Market Share by Players (2017-2022)
3.2 Global CAR T-Cell Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by CAR T-Cell Therapy Revenue
3.4 Global CAR T-Cell Therapy Market Concentration Ratio
3.4.1 Global CAR T-Cell Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by CAR T-Cell Therapy Revenue in 2021
3.5 CAR T-Cell Therapy Key Players Head office and Area Served
3.6 Key Players CAR T-Cell Therapy Product Solution and Service
3.7 Date of Enter into CAR T-Cell Therapy Market
3.8 Mergers & Acquisitions, Expansion Plans
4 CAR T-Cell Therapy Breakdown Data by Type
4.1 Global CAR T-Cell Therapy Historic Market Size by Type (2017-2022)
4.2 Global CAR T-Cell Therapy Forecasted Market Size by Type (2023-2028)
5 CAR T-Cell Therapy Breakdown Data by Application
5.1 Global CAR T-Cell Therapy Historic Market Size by Application (2017-2022)
5.2 Global CAR T-Cell Therapy Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America CAR T-Cell Therapy Market Size (2017-2028)
6.2 North America CAR T-Cell Therapy Market Size by Type
6.2.1 North America CAR T-Cell Therapy Market Size by Type (2017-2022)
6.2.2 North America CAR T-Cell Therapy Market Size by Type (2023-2028)
6.2.3 North America CAR T-Cell Therapy Market Share by Type (2017-2028)
6.3 North America CAR T-Cell Therapy Market Size by Application
6.3.1 North America CAR T-Cell Therapy Market Size by Application (2017-2022)
6.3.2 North America CAR T-Cell Therapy Market Size by Application (2023-2028)
6.3.3 North America CAR T-Cell Therapy Market Share by Application (2017-2028)
6.4 North America CAR T-Cell Therapy Market Size by Country
6.4.1 North America CAR T-Cell Therapy Market Size by Country (2017-2022)
6.4.2 North America CAR T-Cell Therapy Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe CAR T-Cell Therapy Market Size (2017-2028)
7.2 Europe CAR T-Cell Therapy Market Size by Type
7.2.1 Europe CAR T-Cell Therapy Market Size by Type (2017-2022)
7.2.2 Europe CAR T-Cell Therapy Market Size by Type (2023-2028)
7.2.3 Europe CAR T-Cell Therapy Market Share by Type (2017-2028)
7.3 Europe CAR T-Cell Therapy Market Size by Application
7.3.1 Europe CAR T-Cell Therapy Market Size by Application (2017-2022)
7.3.2 Europe CAR T-Cell Therapy Market Size by Application (2023-2028)
7.3.3 Europe CAR T-Cell Therapy Market Share by Application (2017-2028)
7.4 Europe CAR T-Cell Therapy Market Size by Country
7.4.1 Europe CAR T-Cell Therapy Market Size by Country (2017-2022)
7.4.2 Europe CAR T-Cell Therapy Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific CAR T-Cell Therapy Market Size (2017-2028)
8.2 Asia-Pacific CAR T-Cell Therapy Market Size by Type
8.2.1 Asia-Pacific CAR T-Cell Therapy Market Size by Type (2017-2022)
8.2.2 Asia-Pacific CAR T-Cell Therapy Market Size by Type (2023-2028)
8.2.3 Asia-Pacific CAR T-Cell Therapy Market Share by Type (2017-2028)
8.3 Asia-Pacific CAR T-Cell Therapy Market Size by Application
8.3.1 Asia-Pacific CAR T-Cell Therapy Market Size by Application (2017-2022)
8.3.2 Asia-Pacific CAR T-Cell Therapy Market Size by Application (2023-2028)
8.3.3 Asia-Pacific CAR T-Cell Therapy Market Share by Application (2017-2028)
8.4 Asia-Pacific CAR T-Cell Therapy Market Size by Region
8.4.1 Asia-Pacific CAR T-Cell Therapy Market Size by Region (2017-2022)
8.4.2 Asia-Pacific CAR T-Cell Therapy Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America CAR T-Cell Therapy Market Size (2017-2028)
9.2 Latin America CAR T-Cell Therapy Market Size by Type
9.2.1 Latin America CAR T-Cell Therapy Market Size by Type (2017-2022)
9.2.2 Latin America CAR T-Cell Therapy Market Size by Type (2023-2028)
9.2.3 Latin America CAR T-Cell Therapy Market Share by Type (2017-2028)
9.3 Latin America CAR T-Cell Therapy Market Size by Application
9.3.1 Latin America CAR T-Cell Therapy Market Size by Application (2017-2022)
9.3.2 Latin America CAR T-Cell Therapy Market Size by Application (2023-2028)
9.3.3 Latin America CAR T-Cell Therapy Market Share by Application (2017-2028)
9.4 Latin America CAR T-Cell Therapy Market Size by Country
9.4.1 Latin America CAR T-Cell Therapy Market Size by Country (2017-2022)
9.4.2 Latin America CAR T-Cell Therapy Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa CAR T-Cell Therapy Market Size (2017-2028)
10.2 Middle East & Africa CAR T-Cell Therapy Market Size by Type
10.2.1 Middle East & Africa CAR T-Cell Therapy Market Size by Type (2017-2022)
10.2.2 Middle East & Africa CAR T-Cell Therapy Market Size by Type (2023-2028)
10.2.3 Middle East & Africa CAR T-Cell Therapy Market Share by Type (2017-2028)
10.3 Middle East & Africa CAR T-Cell Therapy Market Size by Application
10.3.1 Middle East & Africa CAR T-Cell Therapy Market Size by Application (2017-2022)
10.3.2 Middle East & Africa CAR T-Cell Therapy Market Size by Application (2023-2028)
10.3.3 Middle East & Africa CAR T-Cell Therapy Market Share by Application (2017-2028)
10.4 Middle East & Africa CAR T-Cell Therapy Market Size by Country
10.4.1 Middle East & Africa CAR T-Cell Therapy Market Size by Country (2017-2022)
10.4.2 Middle East & Africa CAR T-Cell Therapy Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Celgene (Juno Therapeutics)
11.1.1 Celgene (Juno Therapeutics) Company Details
11.1.2 Celgene (Juno Therapeutics) Business Overview
11.1.3 Celgene (Juno Therapeutics) CAR T-Cell Therapy Introduction
11.1.4 Celgene (Juno Therapeutics) Revenue in CAR T-Cell Therapy Business (2017-2022)
11.1.5 Celgene (Juno Therapeutics) Recent Developments
11.2 Novartis
11.2.1 Novartis Company Details
11.2.2 Novartis Business Overview
11.2.3 Novartis CAR T-Cell Therapy Introduction
11.2.4 Novartis Revenue in CAR T-Cell Therapy Business (2017-2022)
11.2.5 Novartis Recent Developments
11.3 Gilead (Kite Pharma)
11.3.1 Gilead (Kite Pharma) Company Details
11.3.2 Gilead (Kite Pharma) Business Overview
11.3.3 Gilead (Kite Pharma) CAR T-Cell Therapy Introduction
11.3.4 Gilead (Kite Pharma) Revenue in CAR T-Cell Therapy Business (2017-2022)
11.3.5 Gilead (Kite Pharma) Recent Developments
11.4 Pfizer
11.4.1 Pfizer Company Details
11.4.2 Pfizer Business Overview
11.4.3 Pfizer CAR T-Cell Therapy Introduction
11.4.4 Pfizer Revenue in CAR T-Cell Therapy Business (2017-2022)
11.4.5 Pfizer Recent Developments
11.5 CARsgen Therapeutics
11.5.1 CARsgen Therapeutics Company Details
11.5.2 CARsgen Therapeutics Business Overview
11.5.3 CARsgen Therapeutics CAR T-Cell Therapy Introduction
11.5.4 CARsgen Therapeutics Revenue in CAR T-Cell Therapy Business (2017-2022)
11.5.5 CARsgen Therapeutics Recent Developments
11.6 Autolus Therapeutics
11.6.1 Autolus Therapeutics Company Details
11.6.2 Autolus Therapeutics Business Overview
11.6.3 Autolus Therapeutics CAR T-Cell Therapy Introduction
11.6.4 Autolus Therapeutics Revenue in CAR T-Cell Therapy Business (2017-2022)
11.6.5 Autolus Therapeutics Recent Developments
11.7 Aurora BioPharma
11.7.1 Aurora BioPharma Company Details
11.7.2 Aurora BioPharma Business Overview
11.7.3 Aurora BioPharma CAR T-Cell Therapy Introduction
11.7.4 Aurora BioPharma Revenue in CAR T-Cell Therapy Business (2017-2022)
11.7.5 Aurora BioPharma Recent Developments
11.8 Sorrento Therapeutics
11.8.1 Sorrento Therapeutics Company Details
11.8.2 Sorrento Therapeutics Business Overview
11.8.3 Sorrento Therapeutics CAR T-Cell Therapy Introduction
11.8.4 Sorrento Therapeutics Revenue in CAR T-Cell Therapy Business (2017-2022)
11.8.5 Sorrento Therapeutics Recent Developments
11.9 Mustang Bio
11.9.1 Mustang Bio Company Details
11.9.2 Mustang Bio Business Overview
11.9.3 Mustang Bio CAR T-Cell Therapy Introduction
11.9.4 Mustang Bio Revenue in CAR T-Cell Therapy Business (2017-2022)
11.9.5 Mustang Bio Recent Developments
11.10 Bluebird Bio
11.10.1 Bluebird Bio Company Details
11.10.2 Bluebird Bio Business Overview
11.10.3 Bluebird Bio CAR T-Cell Therapy Introduction
11.10.4 Bluebird Bio Revenue in CAR T-Cell Therapy Business (2017-2022)
11.10.5 Bluebird Bio Recent Developments
11.11 Collectis
11.11.1 Collectis Company Details
11.11.2 Collectis Business Overview
11.11.3 Collectis CAR T-Cell Therapy Introduction
11.11.4 Collectis Revenue in CAR T-Cell Therapy Business (2017-2022)
11.11.5 Collectis Recent Developments
11.12 Allogene Therapeutics
11.12.1 Allogene Therapeutics Company Details
11.12.2 Allogene Therapeutics Business Overview
11.12.3 Allogene Therapeutics CAR T-Cell Therapy Introduction
11.12.4 Allogene Therapeutics Revenue in CAR T-Cell Therapy Business (2017-2022)
11.12.5 Allogene Therapeutics Recent Developments
11.13 Celyad
11.13.1 Celyad Company Details
11.13.2 Celyad Business Overview
11.13.3 Celyad CAR T-Cell Therapy Introduction
11.13.4 Celyad Revenue in CAR T-Cell Therapy Business (2017-2022)
11.13.5 Celyad Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global CAR T-Cell Therapy Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Allogeneic
Table 3. Key Players of Autologous
Table 4. Global CAR T-Cell Therapy Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 5. Global CAR T-Cell Therapy Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 6. Global CAR T-Cell Therapy Market Size by Region (2017-2022) & (US$ Million)
Table 7. Global CAR T-Cell Therapy Market Share by Region (2017-2022)
Table 8. Global CAR T-Cell Therapy Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 9. Global CAR T-Cell Therapy Market Share by Region (2023-2028)
Table 10. CAR T-Cell Therapy Market Trends
Table 11. CAR T-Cell Therapy Market Drivers
Table 12. CAR T-Cell Therapy Market Challenges
Table 13. CAR T-Cell Therapy Market Restraints
Table 14. Global CAR T-Cell Therapy Revenue by Players (2017-2022) & (US$ Million)
Table 15. Global CAR T-Cell Therapy Revenue Share by Players (2017-2022)
Table 16. Global Top CAR T-Cell Therapy by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CAR T-Cell Therapy as of 2021)
Table 17. Ranking of Global Top CAR T-Cell Therapy Companies by Revenue (US$ Million) in 2021
Table 18. Global 5 Largest Players Market Share by CAR T-Cell Therapy Revenue (CR5 and HHI) & (2017-2022)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players CAR T-Cell Therapy Product Solution and Service
Table 21. Date of Enter into CAR T-Cell Therapy Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global CAR T-Cell Therapy Market Size by Type (2017-2022) & (US$ Million)
Table 24. Global CAR T-Cell Therapy Revenue Market Share by Type (2017-2022)
Table 25. Global CAR T-Cell Therapy Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 26. Global CAR T-Cell Therapy Revenue Market Share by Type (2023-2028)
Table 27. Global CAR T-Cell Therapy Market Size by Application (2017-2022) & (US$ Million)
Table 28. Global CAR T-Cell Therapy Revenue Share by Application (2017-2022)
Table 29. Global CAR T-Cell Therapy Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 30. Global CAR T-Cell Therapy Revenue Share by Application (2023-2028)
Table 31. North America CAR T-Cell Therapy Market Size by Type (2017-2022) & (US$ Million)
Table 32. North America CAR T-Cell Therapy Market Size by Type (2023-2028) & (US$ Million)
Table 33. North America CAR T-Cell Therapy Market Size by Application (2017-2022) & (US$ Million)
Table 34. North America CAR T-Cell Therapy Market Size by Application (2023-2028) & (US$ Million)
Table 35. North America CAR T-Cell Therapy Market Size by Country (2017-2022) & (US$ Million)
Table 36. North America CAR T-Cell Therapy Market Size by Country (2023-2028) & (US$ Million)
Table 37. Europe CAR T-Cell Therapy Market Size by Type (2017-2022) & (US$ Million)
Table 38. Europe CAR T-Cell Therapy Market Size by Type (2023-2028) & (US$ Million)
Table 39. Europe CAR T-Cell Therapy Market Size by Application (2017-2022) & (US$ Million)
Table 40. Europe CAR T-Cell Therapy Market Size by Application (2023-2028) & (US$ Million)
Table 41. Europe CAR T-Cell Therapy Market Size by Country (2017-2022) & (US$ Million)
Table 42. Europe CAR T-Cell Therapy Market Size by Country (2023-2028) & (US$ Million)
Table 43. Asia Pacific CAR T-Cell Therapy Market Size by Type (2017-2022) & (US$ Million)
Table 44. Asia Pacific CAR T-Cell Therapy Market Size by Type (2023-2028) & (US$ Million)
Table 45. Asia Pacific CAR T-Cell Therapy Market Size by Application (2017-2022) & (US$ Million)
Table 46. Asia Pacific CAR T-Cell Therapy Market Size by Application (2023-2028) & (US$ Million)
Table 47. Asia Pacific CAR T-Cell Therapy Market Size by Region (2017-2022) & (US$ Million)
Table 48. Asia Pacific CAR T-Cell Therapy Market Size by Region (2023-2028) & (US$ Million)
Table 49. Latin America CAR T-Cell Therapy Market Size by Type (2017-2022) & (US$ Million)
Table 50. Latin America CAR T-Cell Therapy Market Size by Type (2023-2028) & (US$ Million)
Table 51. Latin America CAR T-Cell Therapy Market Size by Application (2017-2022) & (US$ Million)
Table 52. Latin America CAR T-Cell Therapy Market Size by Application (2023-2028) & (US$ Million)
Table 53. Latin America CAR T-Cell Therapy Market Size by Country (2017-2022) & (US$ Million)
Table 54. Latin America CAR T-Cell Therapy Market Size by Country (2023-2028) & (US$ Million)
Table 55. Middle East and Africa CAR T-Cell Therapy Market Size by Type (2017-2022) & (US$ Million)
Table 56. Middle East and Africa CAR T-Cell Therapy Market Size by Type (2023-2028) & (US$ Million)
Table 57. Middle East and Africa CAR T-Cell Therapy Market Size by Application (2017-2022) & (US$ Million)
Table 58. Middle East and Africa CAR T-Cell Therapy Market Size by Application (2023-2028) & (US$ Million)
Table 59. Middle East and Africa CAR T-Cell Therapy Market Size by Country (2017-2022) & (US$ Million)
Table 60. Middle East and Africa CAR T-Cell Therapy Market Size by Country (2023-2028) & (US$ Million)
Table 61. Celgene (Juno Therapeutics) Company Details
Table 62. Celgene (Juno Therapeutics) Business Overview
Table 63. Celgene (Juno Therapeutics) CAR T-Cell Therapy Product
Table 64. Celgene (Juno Therapeutics) Revenue in CAR T-Cell Therapy Business (2017-2022) & (US$ Million)
Table 65. Celgene (Juno Therapeutics) Recent Developments
Table 66. Novartis Company Details
Table 67. Novartis Business Overview
Table 68. Novartis CAR T-Cell Therapy Product
Table 69. Novartis Revenue in CAR T-Cell Therapy Business (2017-2022) & (US$ Million)
Table 70. Novartis Recent Developments
Table 71. Gilead (Kite Pharma) Company Details
Table 72. Gilead (Kite Pharma) Business Overview
Table 73. Gilead (Kite Pharma) CAR T-Cell Therapy Product
Table 74. Gilead (Kite Pharma) Revenue in CAR T-Cell Therapy Business (2017-2022) & (US$ Million)
Table 75. Gilead (Kite Pharma) Recent Developments
Table 76. Pfizer Company Details
Table 77. Pfizer Business Overview
Table 78. Pfizer CAR T-Cell Therapy Product
Table 79. Pfizer Revenue in CAR T-Cell Therapy Business (2017-2022) & (US$ Million)
Table 80. Pfizer Recent Developments
Table 81. CARsgen Therapeutics Company Details
Table 82. CARsgen Therapeutics Business Overview
Table 83. CARsgen Therapeutics CAR T-Cell Therapy Product
Table 84. CARsgen Therapeutics Revenue in CAR T-Cell Therapy Business (2017-2022) & (US$ Million)
Table 85. CARsgen Therapeutics Recent Developments
Table 86. Autolus Therapeutics Company Details
Table 87. Autolus Therapeutics Business Overview
Table 88. Autolus Therapeutics CAR T-Cell Therapy Product
Table 89. Autolus Therapeutics Revenue in CAR T-Cell Therapy Business (2017-2022) & (US$ Million)
Table 90. Autolus Therapeutics Recent Developments
Table 91. Aurora BioPharma Company Details
Table 92. Aurora BioPharma Business Overview
Table 93. Aurora BioPharma CAR T-Cell Therapy Product
Table 94. Aurora BioPharma Revenue in CAR T-Cell Therapy Business (2017-2022) & (US$ Million)
Table 95. Aurora BioPharma Recent Developments
Table 96. Sorrento Therapeutics Company Details
Table 97. Sorrento Therapeutics Business Overview
Table 98. Sorrento Therapeutics CAR T-Cell Therapy Product
Table 99. Sorrento Therapeutics Revenue in CAR T-Cell Therapy Business (2017-2022) & (US$ Million)
Table 100. Sorrento Therapeutics Recent Developments
Table 101. Mustang Bio Company Details
Table 102. Mustang Bio Business Overview
Table 103. Mustang Bio CAR T-Cell Therapy Product
Table 104. Mustang Bio Revenue in CAR T-Cell Therapy Business (2017-2022) & (US$ Million)
Table 105. Mustang Bio Recent Developments
Table 106. Bluebird Bio Company Details
Table 107. Bluebird Bio Business Overview
Table 108. Bluebird Bio CAR T-Cell Therapy Product
Table 109. Bluebird Bio Revenue in CAR T-Cell Therapy Business (2017-2022) & (US$ Million)
Table 110. Bluebird Bio Recent Developments
Table 111. Collectis Company Details
Table 112. Collectis Business Overview
Table 113. Collectis CAR T-Cell Therapy Product
Table 114. Collectis Revenue in CAR T-Cell Therapy Business (2017-2022) & (US$ Million)
Table 115. Collectis Recent Developments
Table 116. Allogene Therapeutics Company Details
Table 117. Allogene Therapeutics Business Overview
Table 118. Allogene Therapeutics CAR T-Cell Therapy Product
Table 119. Allogene Therapeutics Revenue in CAR T-Cell Therapy Business (2017-2022) & (US$ Million)
Table 120. Allogene Therapeutics Recent Developments
Table 121. Celyad Company Details
Table 122. Celyad Business Overview
Table 123. Celyad CAR T-Cell Therapy Product
Table 124. Celyad Revenue in CAR T-Cell Therapy Business (2017-2022) & (US$ Million)
Table 125. Celyad Recent Developments
Table 126. Research Programs/Design for This Report
Table 127. Key Data Information from Secondary Sources
Table 128. Key Data Information from Primary Sources
List of Figures
Figure 1. Global CAR T-Cell Therapy Market Share by Type: 2021 VS 2028
Figure 2. Allogeneic Features
Figure 3. Autologous Features
Figure 4. Global CAR T-Cell Therapy Market Share by Application: 2021 VS 2028
Figure 5. Hospitals Case Studies
Figure 6. Cancer Research Centers Case Studies
Figure 7. Others Case Studies
Figure 8. CAR T-Cell Therapy Report Years Considered
Figure 9. Global CAR T-Cell Therapy Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 10. Global CAR T-Cell Therapy Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 11. Global CAR T-Cell Therapy Market Share by Region: 2021 VS 2028
Figure 12. Global CAR T-Cell Therapy Market Share by Players in 2021
Figure 13. Global Top CAR T-Cell Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CAR T-Cell Therapy as of 2021)
Figure 14. The Top 10 and 5 Players Market Share by CAR T-Cell Therapy Revenue in 2021
Figure 15. North America CAR T-Cell Therapy Market Size YoY (2017-2028) & (US$ Million)
Figure 16. North America CAR T-Cell Therapy Market Size Market Share by Type (2017-2028)
Figure 17. North America CAR T-Cell Therapy Market Size Market Share by Application (2017-2028)
Figure 18. North America CAR T-Cell Therapy Market Size Share by Country (2017-2028)
Figure 19. United States CAR T-Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 20. Canada CAR T-Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 21. Europe CAR T-Cell Therapy Market Size YoY (2017-2028) & (US$ Million)
Figure 22. Europe CAR T-Cell Therapy Market Size Market Share by Type (2017-2028)
Figure 23. Europe CAR T-Cell Therapy Market Size Market Share by Application (2017-2028)
Figure 24. Europe CAR T-Cell Therapy Market Size Share by Country (2017-2028)
Figure 25. Germany CAR T-Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. France CAR T-Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. U.K. CAR T-Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. Italy CAR T-Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Russia CAR T-Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Nordic Countries CAR T-Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Asia-Pacific CAR T-Cell Therapy Market Size YoY (2017-2028) & (US$ Million)
Figure 32. Asia Pacific CAR T-Cell Therapy Market Size Market Share by Type (2017-2028)
Figure 33. Asia Pacific CAR T-Cell Therapy Market Size Market Share by Application (2017-2028)
Figure 34. Asia Pacific CAR T-Cell Therapy Market Size Share by Region (2017-2028)
Figure 35. China CAR T-Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. Japan CAR T-Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. South Korea CAR T-Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Southeast Asia CAR T-Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. India CAR T-Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Australia CAR T-Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
Figure 41. Latin America CAR T-Cell Therapy Market Size YoY (2017-2028) & (US$ Million)
Figure 42. Latin America CAR T-Cell Therapy Market Size Market Share by Type (2017-2028)
Figure 43. Latin America CAR T-Cell Therapy Market Size Market Share by Application (2017-2028)
Figure 44. Latin America CAR T-Cell Therapy Market Size Share by Country (2017-2028)
Figure 45. Mexico CAR T-Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 46. Brazil CAR T-Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 47. Middle East & Africa CAR T-Cell Therapy Market Size YoY (2017-2028) & (US$ Million)
Figure 48. Middle East and Africa CAR T-Cell Therapy Market Size Market Share by Type (2017-2028)
Figure 49. Middle East and Africa CAR T-Cell Therapy Market Size Market Share by Application (2017-2028)
Figure 50. Middle East and Africa CAR T-Cell Therapy Market Size Share by Country (2017-2028)
Figure 51. Turkey CAR T-Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 52. Saudi Arabia CAR T-Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 53. UAE CAR T-Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 54. Celgene (Juno Therapeutics) Revenue Growth Rate in CAR T-Cell Therapy Business (2017-2022)
Figure 55. Novartis Revenue Growth Rate in CAR T-Cell Therapy Business (2017-2022)
Figure 56. Gilead (Kite Pharma) Revenue Growth Rate in CAR T-Cell Therapy Business (2017-2022)
Figure 57. Pfizer Revenue Growth Rate in CAR T-Cell Therapy Business (2017-2022)
Figure 58. CARsgen Therapeutics Revenue Growth Rate in CAR T-Cell Therapy Business (2017-2022)
Figure 59. Autolus Therapeutics Revenue Growth Rate in CAR T-Cell Therapy Business (2017-2022)
Figure 60. Aurora BioPharma Revenue Growth Rate in CAR T-Cell Therapy Business (2017-2022)
Figure 61. Sorrento Therapeutics Revenue Growth Rate in CAR T-Cell Therapy Business (2017-2022)
Figure 62. Mustang Bio Revenue Growth Rate in CAR T-Cell Therapy Business (2017-2022)
Figure 63. Bluebird Bio Revenue Growth Rate in CAR T-Cell Therapy Business (2017-2022)
Figure 64. Collectis Revenue Growth Rate in CAR T-Cell Therapy Business (2017-2022)
Figure 65. Allogene Therapeutics Revenue Growth Rate in CAR T-Cell Therapy Business (2017-2022)
Figure 66. Celyad Revenue Growth Rate in CAR T-Cell Therapy Business (2017-2022)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed
Buy
